(Total Views: 237)
Posted On: 05/04/2021 10:31:36 AM
Post# of 36566
We need 3 things:
1). We need the IND put in to the US FDA
2). We need the IND put in to the China FDA
3). We need the listing of NGIO
The technology is there and actually has a history. The testing so far has been successful. They need to implement and get it done 'now'.
That will move the proverbial PPS needle'.
Wishful thinking on the part of everyone or what ifs has not done it or projections over the last several years and dilution of stock has only hurt the PPS.
So, announcing the INDs and acceptance to move into the trials and the listing will be the only thing that moves the PPS going forward outside of any hard revenues coming in.
1). We need the IND put in to the US FDA
2). We need the IND put in to the China FDA
3). We need the listing of NGIO
The technology is there and actually has a history. The testing so far has been successful. They need to implement and get it done 'now'.
That will move the proverbial PPS needle'.
Wishful thinking on the part of everyone or what ifs has not done it or projections over the last several years and dilution of stock has only hurt the PPS.
So, announcing the INDs and acceptance to move into the trials and the listing will be the only thing that moves the PPS going forward outside of any hard revenues coming in.
(1)
(0)
